M&R CAPITAL MANAGEMENT INC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
M&R CAPITAL MANAGEMENT INC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$4,000
+33.3%
2000.0%0.00%0.0%
Q1 2018$3,000
-25.0%
2000.0%0.00%0.0%
Q4 2017$4,000
+100.0%
2000.0%0.00%
Q3 2017$2,0000.0%2000.0%0.00%
Q2 2017$2,0000.0%2000.0%0.00%
-100.0%
Q1 2017$2,0000.0%2000.0%0.00%0.0%
Q4 2016$2,000
-50.0%
2000.0%0.00%0.0%
Q3 2016$4,000
-92.0%
200
-92.1%
0.00%
-93.3%
Q2 2016$50,000
-97.3%
2,530
-96.4%
0.02%
-97.3%
Q1 2016$1,863,000
-75.2%
70,854
-4.2%
0.56%
-74.1%
Q4 2015$7,516,000
-47.3%
73,938
-7.5%
2.17%
-44.9%
Q3 2015$14,263,000
-21.7%
79,960
-2.5%
3.94%
-8.7%
Q2 2015$18,227,000
+6.2%
82,049
-5.1%
4.31%
+6.2%
Q1 2015$17,170,000
+38.0%
86,446
-0.6%
4.06%
+37.5%
Q4 2014$12,444,000
+4.0%
86,952
-4.6%
2.95%
+4.2%
Q3 2014$11,962,000
+1.8%
91,176
-2.1%
2.83%
+2.8%
Q2 2014$11,746,000
-3.1%
93,131
+1.3%
2.76%
-5.7%
Q1 2014$12,116,000
+19.6%
91,908
+6.5%
2.92%
+10.3%
Q4 2013$10,130,000
+8.8%
86,285
-3.3%
2.65%
+1.4%
Q3 2013$9,314,000
+29.7%
89,270
+7.0%
2.62%
+26.5%
Q2 2013$7,180,00083,4052.07%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2018
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders